Cited 0 time in
A novel gutless adenoviral vector encoding sphingosine kinase promotes arteriogenesis and improves perfusion in a rabbit hindlimb ischemia model
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 신진호 | - |
| dc.date.accessioned | 2021-08-04T06:03:10Z | - |
| dc.date.available | 2021-08-04T06:03:10Z | - |
| dc.date.issued | 2004-04-06 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/74673 | - |
| dc.description.abstract | Background: We previously demonstrated that sphingosine kinase can increase the level of extracellular sphingosine 1 phosphate and promote arteriogenesis in a mouse model. The present study was designed to test the hypothesis that SPK gene transfer using a novel gutless adenoviral vector can enhance artriogenesis. Methods: 35 male New Zealand White rabbit were assigned to three groups; SPK group(n=13), null group(n=13), and control group(n=9). At day 10 after the induction of unilateral hind-limb ischemia, gene vectors or buffer were introduced and the effect was examined at day 30 suing calf blood pressure, quantitative angiographic analysis and histology. Result: SPK group resulted higher systolic bloos pressure ratio than control groups(0.89+/- 0.04 vs 0.77 +/-0.04, p=0.01) Increased larger neovessels in histology was noted in SPK group(14.7 +/-1.6 vs 12.8+/- 2.5 p=0.54) Conclusion: The result of this study showthat SPK may promote arteriogenesis. | - |
| dc.title | A novel gutless adenoviral vector encoding sphingosine kinase promotes arteriogenesis and improves perfusion in a rabbit hindlimb ischemia model | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | Angioplasty Summit | - |
| dc.citation.conferencePlace | Sheraton Seoul | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
